Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
Clin Inf Dis 41:634-653, Roden, M.M.,et al, 2005
The Clinical-DWI Mismatch
Neurol 62:2187-2192, Davalos,A.,et al, 2004
Management of Myasthenia Gravis
Semin Neurol 24:41-48, Saperstein,D.S. &Barohn,R.J., 2004
Clinicopath Conf., Progessive Multifocal Leukoencephalopathy
NEJM 350:1884-1893, Case 14-2004, 2004
Practice Parameter:Immunotherapy for Guillain-Barre Syndrome, Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurol 61:736-740, Hughes,R.A.C.,et al, 2003
Symmetric Deep Cerebellar Lesions After Smoking Heroin
Arch Neurol 60:1605-1606, Ropper,A.H. &Blair,R., 2003
Treatment of Autoimmune Myasthenia Gravis
Neurol 61:1652-1661, Richman,D.P. & Agius,M.A., 2003
Management of Drug and Alcohol Withdrawal
NEJM 348:1786-1795, Kosten,T.R. &O'Connor,P.G., 2003
Major Risk Factors for Aneurysmal Subarrachnoid Hemorrhage in the Young are Modifiable
Stroke 34:1375-1381, Broderick,J.P.,et al, 2003
Neurotoxicity Following Addition of Intravenous Valproate to Lamotrigine Therapy
Neurol 60:1991-1992, Burneo,J.G.,et al, 2003
Disease Modifying Therapies in Multiple Sclerosis
Neurol 58:169-178, Goodin,D.S.,et al, 2002
Acute Dystonic Reactions to "Street Xanax"
NEJM 346:1753, Hendrickson,R.G.,et al, 2002
Brown-Sequard Syndrome After Esophageal Sclerotherapy and Crack Cocaine Abuse
Neurol 58:1129-1130, Mueller,D. &Gilden,D.H., 2002
Intracerebral Hemorrhages Associated with Neurointerventional Procedures Using a Combination of Antithrombotic Agents Including Abciximab
Stroke 33:1916-1919, Qureshi,A.I.,et al, 2002
Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke
Neurol 59:13-22, Coull,B.M.,et al, 2002
Systematic Review of Immunomodulatory Drugs for the Treatment of People with Multiple Sclerosis: Is There Good Quality Evidence on Effectiveness and Cost?
JNNP 70:574-579, Bryan,J.,et al, 2001
Toxic Leukoencephalopathy
NEJM 345:425-432, Filley,C.M. &Kleinschmidt-DeMasters,B.K., 2001
Risk of Stroke Associated With Abciximab Among Patients Undergoing Percutaneous Coronary Intervention
JAMA 286:78-82, Akkerhuis,K.M.,et al, 2001
Extracranial Carotid Stenosis
NEJM 345:1113-1118, Sacco,R., 2001
Course and Treatment of Myasthenia Gravis During Pregnancy
Neurol 52:447-452, Batocchi,A.P.,et al, 1999
Prevalence of Peripheral Neuropathy in Injection Drug Users
Neurol 53:592-597, Berger,A.R.,et al, 1999
Treatment and Secondary Prevention of Stroke:Evidence, Costs, and Effects on Individuals and Populations
Lancet 354:1457-1463, Hankey,G.J.&Warlow,C.P., 1999
Leukoencephalopathy and Raised Brain Lactate from Heroin Vapor Inhalation ("Chasing the Dragon")
Neurol 53:589-1048, Kriegstein,A.R., et al, 1999
Hypoxic/Ischaemic Brain Damages, Especially Pallidal Lesions, in Heroin Addicts
Forensic Sci Int 102:51-59, Andersen,S.N. &Skullerud,K., 1999
Influence of Human Immunodeficiency Virus 1 Infection and Degree of Immunosuppression in the Clinical Characteristics and Outcome of Infective Endocarditis in Intravenous Drug Users
Arch Int Med 158:2043-2050, Ribera,E.,et al, 1998
Myelopathy Caused by Nitrous Oxide Toxicity
AJNR 19:894-896, 9941998., Pema,P.J.,et al, 1998
Clinicopath Conf
Subacute Sclerosing Panencephalitis, Case 15-1998, NEJM 338:1448-1456998., , 1998
Importance of Hemodynamic Factors in the Prognosis of Symptomatic Carotid Occlusion
JAMA 280:1055-1060, 10931998., Grubb,R.L.,et al, 1998
Treatment of Inflammatory Myopathies
Muscle & Nerve 20:651-664997., Mastaglia,F.L.,et al, 1997
Treatment of Acquired Myasthenia Gravis
Neurol 48 (Suppl 5) :S46-S51997., Massey,J.M., 1997
Acute Bacterial Meningitis in Adults, A 20-Yr Overview
Arch Int Med 157:425-430, Sigurdardottir,B.,et al, 1997
Gluteal Compartment Syndrome Due to Rhabdomyolysis After Heroin Abuse
Neurol 48:275-276, Klockgether,T.,et al, 1997
Aluminum Neurotoxicity in Preterm Infants Receiving Intravenous-Feeding Solutions
NEJM 336:1557-1561, Bishop,N.J.,et al, 1997
Cocaine-Associated Dystonic Reaction
Am J Emerg Med 15:513-516, Fines,R.E.,et al, 1997
Management of Multiple Sclerosis
NEJM 337:1604-1611, Rudick,R.A.,et al, 1997
Ecstasy and Neurodegeneration
BMJ 312:1493, Green,A.R.&Goodwin,G.M., 1996
Manganese Toxicity in Children Receiving Long-Term Parental Nutrition
Lancet 347:1218-1221, Fell,J.M.E.,et al, 1996
Postherpetic Neuralgia-Pathogenesis, Treatment and Prevention
NEJM 335:32-42, Kost,R.G.&Straus,S.E., 1996
Concern About Safety of Carotid Angioplasty
Stroke 27:197-198, Beebe,H.G.,et al, 1996
The Residual Cognitive Effects of Heavy Marijiana Use in College Students
Pope. H. G. & Yurgelun-Todd, D. , JAMA 275:521-527, , 1996
Exacerbation of Myasthenia Gravis Associated with Cocaine Use
Neurol 46:271-272, Daras,M.,et al, 1996
Successful Treatment of Neuropathies in Patients with Diabetes Mellitus
Arch Neurol 52:1053-1061, Krendel,D.A.,et al, 1995
Neuropathic Pain of Peripheral Origin:Advances in Pharmacologic Treatment
Neurol 45 (suppl 8) :s17-s25995., Galer,B.S., 1995
Lambert-Eaton Myasthenic Syndrome:Clinical Diagnosis,Immune-Mediated Mechanisms,and Update on Therapies
Ann Neurol 37:S63-S73, Sanders,D.B., 1995
Neurologic Manifestations of Cocaine Exposure in Childhood
Pediatrics 93:557-560, Mott,S.H.,et al, 1994
A Follow-up Survey of Clinical Practices for the Use of Heparin, Warafarin, & Aspirin
Neurol 44:618-621, Alberts,M.J.,et al, 1994
Stroke:The Way Things Really Are
Stroke 25:1290-1294, Scheinberg,P., 1994
Myasthenia Gravis
NEJM 330:1797-1810, Drachman,D.B., 1994
Cerebral Infarction Following Intravenous Immunoglobulin Therapy for Myasthenia Gravis
Neurol 44:1180-1181, Steg,R.E.&Lefkowitz,D.M., 1994
Neurologic Manifestations of HIV Infection
Ann Int Med 121:769-785, Simpson,D.M.&Tagliati,M., 1994